Imbed Biosciences is a privately held medical device company and innovator of SAM™ Antimicrobial Technology, with both commercially available and emerging solutions for the treatment of chronic and acute wounds. Imbed’s revolutionary platform technology enhances skin regeneration by integrating multiple agents into an ultra-thin, biocompatible matrix to facilitate wound healing.